Identification of a truncated cystatin SA-I as a saliva biomarker for oral squamous cell carcinoma using the SELDI ProteinChip platform

International Journal of Oral and Maxillofacial Surgery

Volumn 39, Issue 1, 2010, Pages 68-74

  Shintani, S ^a   Hamakawa, H ^b   Ueyama, Y ^c   Hatori, M ^a   Toyoshima, T ^a  

^a SHOWA UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cystatin SA I; Oral cancer; Protein chip; Saliva; Tumor marker

Indexed keywords

AMINO ACID; CYSTATIN; CYSTATIN SA I; PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AMINO TERMINAL SEQUENCE; ANALYTICAL EQUIPMENT; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; MOUTH CARCINOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; SALIVA; SALIVA ANALYSIS; SCREENING TEST; SQUAMOUS CELL CARCINOMA; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

AMINO ACID SEQUENCE; CARCINOMA, SQUAMOUS CELL; CYSTEINE PROTEINASE INHIBITORS; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION PROFILING; GINGIVAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM STAGING; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SALIVA; SALIVARY CYSTATINS; SALIVARY PROTEINS AND PEPTIDES; SEQUENCE DELETION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TONGUE NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 74149084375     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2009.10.001     Document Type: Article

References (32)

1. Adam B.L., Vlahou A., Semmes O.J., and Wright Jr. G.L. Proteomic approaches to biomarker discovery in prostate and bladder cancers. Proteomics. 1 (2001) 1264-1270
2. Anker P., Mulcahy H., Chen X.Q., and Stroun M. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev 18 (1999) 65-73
3. Cazares LH, Adam BL, Ward MD, Nasim S, Schellhammer PF, Semmes OJ, Wright GL Jr. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. Clin Cancer Res. 2002; 8:2541-2552. .
4. El-Naggar A.K., Mao L., Staerkel G., Coombes M.M., Tucker S.L., Luna M.A., Clayman G.L., Lippman S., and Goepfert H. Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn 3 (2001) 164-170
5. Espina V., Dettloff K.A., Cowherd S., Petricoin III E.F., and Liotta L.A. Use of proteomic analysis to monitor responses to biological therapies. Expert Opin Biol Ther. 4 (2004) 83-93
6. Gleich L.L., and Salamone F.N. Molecular genetics of head and neck cancer. Cancer Control. 9 (2002) 369-378
7. Guven Y., Satman I., Dinccag N., and Alptekin S. Salivary peroxidase activity in whole saliva of patients with insulin-dependent (type-1) diabetes mellitus. J Clin Periodontol 23 (1996) 879-881
8. Kuwata H., Yip T.T., Yip C.L., Tomita M., and Hutchens T.W. Bactericidal domain of lactoferrin: detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry. Biochem Biophys Res Commun. 245 (1998) 764-773
9. Lawrence H.P. Salivary markers of systemic disease: noninvasive diagnosis of disease and monitoring of general health. J Can Dent Assoc 68 (2002) 170-174
10. Li J., Zhang Z., Rosenzweig J., Wang Y.Y., and Chan D.W. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem. 48 (2002) 1296-1304
11. Liao P.H., Chang Y.C., Huang M.F., Tai K.W., and Chou M.Y. Mutation of p53 gene codon 63 in saliva as a molecular marker for oral squamous cell carcinomas. Oral Oncol 36 (2000) 272-276
12. LinksLi Y., St John M.A., Zhou X., Kim Y., Sinha U., Jordan R.C., Eisele D., Abemayor E., Elashoff D., Park N.H., and Wong D.T. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res. 10 (2004) 8442-8450
13. Malamud D. Oral diagnostic testing for detecting human immunodeficiency virus-1 antibodies: a technology whose time has come. Am J Med 102 (1997) 9-14
14. Merchant M., and Weinberger S.R. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis. 21 (2000) 1164-1177
15. Nawroz H., Koch W., Anker P., Stroun M., and Sidransky D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med. 2 (1996) 1035-1037
16. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci 694 (1993) 72-77
17. Patel V, Leethanakul C, Gutkind JS. New approaches to the understanding of the molecular basis of oral cancer. Crit Rev Oral Biol Med. 2001; 12:55-63. .
18. Petricoin E.F., Ardekani A.M., Hitt B.A., Levine P.J., Fusaro V.A., Steinberg S.M., Mills G.B., Simone C., Fishman D.A., Kohn E.C., and Liotta L.A. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 359 (2002) 572-577
19. Petricoin E.F., 3rd, Ornstein D.K., Paweletz C.P., Ardekani A., Hackett P.S., Hitt B.A., Velassco A., Trucco C., Wiegand L., Wood K., Simone C.B., Levine P.J., Linehan W.M., Emmert-Buck M.R., Steinberg S.M., Kohn E.C., and Liotta L.A. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst. 94 (2002) 1576-1578
20. Rieger-Christ K.M., Mourtzinos A., Lee P.J., Zagha R.M., Cain J., Silverman M., Libertino J.A., and Summerhayes I.C. Identification of fibroblast growth factor receptor mutations in urine sediment DNA samples complements cytology in bladder tumor detection. Cancer (Phila) 98 (2003) 737-744
21. Rosas S.L., Koch W., da Costa Carvalho M.G., Wu L., Califano J., Westra W., Jen J., and Sidransky D. Promoter hypermethylation patterns of p16. O6-methylguanine-DNA-methyl transferase, and death associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res. 61 (2001) 939-942
22. Sanchez-Cespedes M., Esteller M., Wu L., Nawroz-Danish H., Yoo G.H., Koch W.M., Jen J., Herman J.G., and Sidransky D. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res. 60 (2000) 892-895
23. Sidransky D. Nucleic acid-based methods for the detection of cancer. Science (Wash DC) 278 (1997) 1054-1059
24. Smith R.A., Cokkinides V., and Eyre H.J. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin. 53 (2003) 27-43
25. Soltys S.G., Le Q.T., Shi G., Tibshirani R., Giaccia A.J., and Koong A.C. The use of plasma surface enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers. Clin Cancer Res. 10 (2004) 4806-4812
26. Srinivas P.R., Srivastava S., Hanash S., and Wright Jr. G.L. Proteomics in early detection of cancer. Clin Chem. 47 (2001) 1901-1911
27. Streckfus C, Bigler L, Dellinger T, Dai X, Kingman A, Thigpen JT. The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study. Clin Cancer Res 2000; 6:2363-2370. .
28. Tavassoli M., Brunel N., Maher R., Johnson N.W., and Soussi T. p53 antibodies in the saliva of patients with squamous cell carcinoma of the oral cavity. Int J Cancer. 78 (1998) 390-391
29. Wadsworth J.T., Somers K.D., Cazares L.H., Malik G., Adam B.L., Stack Jr. B.C., Wright Jr. G.L., and Semmes O.J. Serum protein profiles to identify head and neck cancer. Clin Cancer Res. 10 (2004) 1625-1632
30. Wadsworth J.T., Somers K.D., Stack Jr. B.C., Cazares L., Malik G., Adam B.L., Wright Jr. G.L., and Semmes O.J. Identification of patients with head and neck cancer using serum protein profiles. Arch Otolaryngol Head Neck Surg. 130 (2004) 98-104
31. Warnakulasuriya S., Soussi T., Maher R., Johnson N.W., and Tavassoli M. Expression of p53 in oral squamous cell carcinoma is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients. J Pathol. 192 (2000) 52-57
32. Wiseman S.M., Stoler D.L., and Anderson G.R. The role of genomic instability in the pathogenesis of squamous cell carcinoma of the head and neck. Surg Oncol Clin N Am. 13 (2004) 1-11